A carregar...

Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses

Toll-like receptor (TLR) 7 agonists are effective in topical application for the immunotherapy of skin cancers, but their performance for the systemic treatment of solid tumors is limited by the development of TLR tolerance. In this study, we describe a novel strategy to overcome TLR tolerance and e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Hotz, Christian, Treinies, Marina, Mottas, Ines, Rötzer, Laurin C., Oberson, Anne, Spagnuolo, Lorenzo, Perdicchio, Maurizio, Spinetti, Thibaud, Herbst, Tina, Bourquin, Carole
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5139637/
https://ncbi.nlm.nih.gov/pubmed/27999742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1232219
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!